What is Savara Inc’s (SVRA) Stock Real Technical Picture?
JMP Securities raised the price target for the Savara Inc (NASDAQ:SVRA) stock to “a Mkt outperform”. The rating was released on February 15, 2024, according to finviz. The research report from Jefferies has upgraded the stock from Hold to Buy, with a price target set at $4. The stock was downgraded by Jefferies, who disclosed […]
What are the chances of Celldex Therapeutics Inc. (CLDX) Stock turning the corner?
TD Cowen raised the price target for the Celldex Therapeutics Inc. (NASDAQ:CLDX) stock to “an Outperform”. The rating was released on December 20, 2023, according to finviz. The research report from Wells Fargo has initiated the stock to Underweight, with a price target set at $21. The stock was initiated by Jefferies, who disclosed in […]
Investing in Rayonier Advanced Materials Inc (RYAM) Stock: Methodology
RBC Capital Mkts raised the price target for the Rayonier Advanced Materials Inc (NYSE:RYAM) stock from “a Sector perform” to “an Outperform”. The rating was released on May 11, 2023, according to finviz. We previously noted in another research note published on January 10, 2023 by RBC Capital Mkts that downgraded the stock from an […]
The future looks bright for Orion Office REIT Inc (ONL) Stock
JMP Securities raised the price target for the Orion Office REIT Inc (NYSE:ONL) stock to “a Mkt perform”. The rating was released on October 19, 2022, according to finviz. Historical Earnings Surprises and Revenue Forecasts This is an average of 0 analysts’ earnings, where the high earnings per share estimate is $0 and the low […]
There Is Nothing Like AMMO Inc (POWW) Stock
ROTH Capital lowered the price target for the AMMO Inc (NASDAQ:POWW) stock from “a Buy” to “a Neutral”. The rating was released on November 15, 2022, according to finviz. The research report from ROTH Capital has initiated the stock to Buy, with a price target set at $9. Historical Earnings Surprises and Revenue Forecasts Profit […]
PTC Therapeutics Inc (PTCT) Stock deserves your attention
Morgan Stanley raised the price target for the PTC Therapeutics Inc (NASDAQ:PTCT) stock from “an Equal-weight” to “an Underweight”. The rating was released on December 19, 2023, according to finviz. The research report from Oppenheimer has upgraded the stock from Perform to Outperform, with a price target set at $165. The stock was downgraded by […]
The high-quality value of Prothena Corporation plc (PRTA) Stock is hidden beneath the surface
BofA Securities lowered the price target for the Prothena Corporation plc (NASDAQ:PRTA) stock from “a Buy” to “a Neutral”. The rating was released on January 30, 2024, according to finviz. The research report from SVB Securities has initiated the stock to Outperform, with a price target set at $80. The stock was initiated by Piper […]
Alto Ingredients Inc (ALTO) Stock is expected to generate profits in the near future
Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock price to increase when earnings exceed market expectations and progressively decrease when earnings do not meet expectations. The firm reported an earnings per share (EPS) of -$0.26 […]
What makes Baozun Inc ADR (BZUN) Stock unique?
China Renaissance raised the price target for the Baozun Inc ADR (NASDAQ:BZUN) stock from “a Buy” to “a Hold”. The rating was released on March 26, 2024, according to finviz. The research report from CLSA has upgraded the stock from Underperform to Outperform, with a price target set at $7. In their research brief published […]
What’s best: jumping in or staying out? Wave Life Sciences Ltd. (WVE) Stock
Leerink Partners raised the price target for the Wave Life Sciences Ltd. (NASDAQ:WVE) stock from “a Market perform” to “an Outperform”. The rating was released on December 19, 2023, according to finviz. The research report from Jefferies has downgraded the stock from Buy to Hold, with a price target set at $5. The stock was […]
